SPRY – ars pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
How Recent Developments Are Shaping the Story for ARS Pharmaceuticals According to Analysts [Yahoo! Finance]
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
ARS Pharmaceuticals (NASDAQ:SPRY) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Why Analysts See the ARS Pharmaceuticals Story Shifting Amid Changing Growth and Market Risks [Yahoo! Finance]
Form 4 ARS Pharmaceuticals, For: Nov 13 Filed by: Dorsey Brian
Form 4 ARS Pharmaceuticals, For: Nov 12 Filed by: Chakma Justin
Form 4 ARS Pharmaceuticals, For: Nov 12 Filed by: Shah Pratik
Form 144 ARS Pharmaceuticals, Filed by: Chakma Justin
Form 144/A ARS Pharmaceuticals, Filed by: Chakma Justin
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.